2-[4-[4,6-bis[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[4,6-bis[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[4,6-bis[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;2-[4-[4,6-bis[4-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;methane;2,4,6-tris[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]pyrimidine;2,4,6-tris[5-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-3-pyridinyl]pyrimidine

C246H264N46O12 — CID 158312841

About 2-[4-[4,6-bis[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[4,6-bis[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[4,6-bis[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;2-[4-[4,6-bis[4-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;methane;2,4,6-tris[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]pyrimidine;2,4,6-tris[5-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-3-pyridinyl]pyrimidine

2-[4-[4,6-bis[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[4,6-bis[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[4,6-bis[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;2-[4-[4,6-bis[4-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;methane;2,4,6-tris[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]pyrimidine;2,4,6-tris[5-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-3-pyridinyl]pyrimidine (PubChem CID 158312841) has the molecular formula C246H264N46O12 and a molecular weight of 4057.13 g/mol. Its IUPAC name is 2-[4-[4,6-bis[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[4,6-bis[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[4,6-bis[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;2-[4-[4,6-bis[4-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;methane;2,4,6-tris[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]pyrimidine;2,4,6-tris[5-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-3-pyridinyl]pyrimidine.

Molecular Properties

• Compound Name: 2-[4-[4,6-bis[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[4,6-bis[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[4,6-bis[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;2-[4-[4,6-bis[4-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;methane;2,4,6-tris[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]pyrimidine;2,4,6-tris[5-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-3-pyridinyl]pyrimidine
• PubChem CID: 158312841
• Molecular Formula: C246H264N46O12
• Molecular Weight: 4057.13 g/mol
• Exact Mass: 4054.15
• IUPAC Name: 2-[4-[4,6-bis[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[4,6-bis[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[4,6-bis[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;2-[4-[4,6-bis[4-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;methane;2,4,6-tris[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]pyrimidine;2,4,6-tris[5-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-3-pyridinyl]pyrimidine
• SMILES: C.CC1(C)CN=C(c2ccc(-c3nc(-c4ccc(C5=NCC(C)(C)O5)cc4)nc(-c4ccc(C5=NCC(C)(C)O5)cc4)n3)cc2)O1.CC1(C)COC(c2ccc(-c3nc(-c4ccc(C5=NC(C)(C)CO5)cc4)nc(-c4ccc(C5=NC(C)(C)CO5)cc4)n3)cc2)=N1.CC1(C)N=C(c2ccc(-c3nc(-c4ccc(C5=NC(C)(C)C(C)(C)O5)cc4)nc(-c4ccc(C5=NC(C)(C)C(C)(C)O5)cc4)n3)cc2)OC1(C)C.CC1(C)N=C(c2ccccc2)N(c2cncc(-c3cc(-c4cncc(N5C(c6ccccc6)=NC(C)(C)C5(C)C)c4)nc(-c4cncc(N5C(c6ccccc6)=NC(C)(C)C5(C)C)c4)n3)c2)C1(C)C.CC1=NC(C)(C)C(C)(C)N1c1cncc(-c2cc(-c3cncc(N4C(C)=NC(C)(C)C4(C)C)c3)nc(-c3cncc(N4C(C)=NC(C)(C)C4(C)C)c3)n2)c1.c1cc(-c2nc(-c3ccc(C4=NCCO4)cc3)nc(-c3ccc(C4=NCCO4)cc3)n2)ccc1C1=NCCO1
• InChI: InChI=1S/C58H61N11.C43H55N11.C42H48N6O3.2C36H36N6O3.C30H24N6O3.CH4/c1-53(2)56(7,8)67(50(64-53)38-22-16-13-17-23-38)44-28-41(32-59-35-44)47-31-48(42-29-45(36-60-33-42)68-51(39-24-18-14-19-25-39)65-54(3,4)57(68,9)10)63-49(62-47)43-30-46(37-61-34-43)69-52(40-26-20-15-21-27-40)66-55(5,6)58(69,11)12;1-26-49-38(4,5)41(10,11)52(26)32-16-29(20-44-23-32)35-19-36(30-17-33(24-45-21-30)53-27(2)50-39(6,7)42(53,12)13)48-37(47-35)31-18-34(25-46-22-31)54-28(3)51-40(8,9)43(54,14)15;1-37(2)40(7,8)49-34(46-37)28-19-13-25(14-20-28)31-43-32(26-15-21-29(22-16-26)35-47-38(3,4)41(9,10)50-35)45-33(44-31)27-17-23-30(24-18-27)36-48-39(5,6)42(11,12)51-36;1-34(2)19-43-31(40-34)25-13-7-22(8-14-25)28-37-29(23-9-15-26(16-10-23)32-41-35(3,4)20-44-32)39-30(38-28)24-11-17-27(18-12-24)33-42-36(5,6)21-45-33;1-34(2)19-37-31(43-34)25-13-7-22(8-14-25)28-40-29(23-9-15-26(16-10-23)32-38-20-35(3,4)44-32)42-30(41-28)24-11-17-27(18-12-24)33-39-21-36(5,6)45-33;1-7-22(28-31-13-16-37-28)8-2-19(1)25-34-26(20-3-9-23(10-4-20)29-32-14-17-38-29)36-27(35-25)21-5-11-24(12-6-21)30-33-15-18-39-30;/h13-37H,1-12H3;16-25H,1-15H3;13-24H,1-12H3;2*7-18H,19-21H2,1-6H3;1-12H,13-18H2;1H4
• InChIKey: GNWUDUDXNACITC-UHFFFAOYSA-N
• XLogP: 47.98
• TPSA: 636.26 Ų
• H-Bond Acceptors: 58
• Rotatable Bonds: 39
• Heavy Atoms: 304
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	4057.13
LogP ≤ 5	47.98
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	58

Frequently Asked Questions

What is the IUPAC name of 2-[4-[4,6-bis[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[4,6-bis[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[4,6-bis[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;2-[4-[4,6-bis[4-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;methane;2,4,6-tris[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]pyrimidine;2,4,6-tris[5-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-3-pyridinyl]pyrimidine?

The IUPAC name of 2-[4-[4,6-bis[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[4,6-bis[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[4,6-bis[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;2-[4-[4,6-bis[4-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;methane;2,4,6-tris[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]pyrimidine;2,4,6-tris[5-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-3-pyridinyl]pyrimidine (CID 158312841) is 2-[4-[4,6-bis[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[4,6-bis[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[4,6-bis[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;2-[4-[4,6-bis[4-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;methane;2,4,6-tris[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]pyrimidine;2,4,6-tris[5-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-3-pyridinyl]pyrimidine.

What is the SMILES notation for 2-[4-[4,6-bis[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[4,6-bis[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[4,6-bis[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;2-[4-[4,6-bis[4-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;methane;2,4,6-tris[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]pyrimidine;2,4,6-tris[5-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-3-pyridinyl]pyrimidine?

The canonical SMILES for 2-[4-[4,6-bis[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[4,6-bis[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[4,6-bis[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;2-[4-[4,6-bis[4-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;methane;2,4,6-tris[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]pyrimidine;2,4,6-tris[5-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-3-pyridinyl]pyrimidine is C.CC1(C)CN=C(c2ccc(-c3nc(-c4ccc(C5=NCC(C)(C)O5)cc4)nc(-c4ccc(C5=NCC(C)(C)O5)cc4)n3)cc2)O1.CC1(C)COC(c2ccc(-c3nc(-c4ccc(C5=NC(C)(C)CO5)cc4)nc(-c4ccc(C5=NC(C)(C)CO5)cc4)n3)cc2)=N1.CC1(C)N=C(c2ccc(-c3nc(-c4ccc(C5=NC(C)(C)C(C)(C)O5)cc4)nc(-c4ccc(C5=NC(C)(C)C(C)(C)O5)cc4)n3)cc2)OC1(C)C.CC1(C)N=C(c2ccccc2)N(c2cncc(-c3cc(-c4cncc(N5C(c6ccccc6)=NC(C)(C)C5(C)C)c4)nc(-c4cncc(N5C(c6ccccc6)=NC(C)(C)C5(C)C)c4)n3)c2)C1(C)C.CC1=NC(C)(C)C(C)(C)N1c1cncc(-c2cc(-c3cncc(N4C(C)=NC(C)(C)C4(C)C)c3)nc(-c3cncc(N4C(C)=NC(C)(C)C4(C)C)c3)n2)c1.c1cc(-c2nc(-c3ccc(C4=NCCO4)cc3)nc(-c3ccc(C4=NCCO4)cc3)n2)ccc1C1=NCCO1.

What is the InChIKey of 2-[4-[4,6-bis[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[4,6-bis[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[4,6-bis[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;2-[4-[4,6-bis[4-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;methane;2,4,6-tris[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]pyrimidine;2,4,6-tris[5-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-3-pyridinyl]pyrimidine?

The InChIKey is GNWUDUDXNACITC-UHFFFAOYSA-N. The full InChI is InChI=1S/C58H61N11.C43H55N11.C42H48N6O3.2C36H36N6O3.C30H24N6O3.CH4/c1-53(2)56(7,8)67(50(64-53)38-22-16-13-17-23-38)44-28-41(32-59-35-44)47-31-48(42-29-45(36-60-33-42)68-51(39-24-18-14-19-25-39)65-54(3,4)57(68,9)10)63-49(62-47)43-30-46(37-61-34-43)69-52(40-26-20-15-21-27-40)66-55(5,6)58(69,11)12;1-26-49-38(4,5)41(10,11)52(26)32-16-29(20-44-23-32)35-19-36(30-17-33(24-45-21-30)53-27(2)50-39(6,7)42(53,12)13)48-37(47-35)31-18-34(25-46-22-31)54-28(3)51-40(8,9)43(54,14)15;1-37(2)40(7,8)49-34(46-37)28-19-13-25(14-20-28)31-43-32(26-15-21-29(22-16-26)35-47-38(3,4)41(9,10)50-35)45-33(44-31)27-17-23-30(24-18-27)36-48-39(5,6)42(11,12)51-36;1-34(2)19-43-31(40-34)25-13-7-22(8-14-25)28-37-29(23-9-15-26(16-10-23)32-41-35(3,4)20-44-32)39-30(38-28)24-11-17-27(18-12-24)33-42-36(5,6)21-45-33;1-34(2)19-37-31(43-34)25-13-7-22(8-14-25)28-40-29(23-9-15-26(16-10-23)32-38-20-35(3,4)44-32)42-30(41-28)24-11-17-27(18-12-24)33-39-21-36(5,6)45-33;1-7-22(28-31-13-16-37-28)8-2-19(1)25-34-26(20-3-9-23(10-4-20)29-32-14-17-38-29)36-27(35-25)21-5-11-24(12-6-21)30-33-15-18-39-30;/h13-37H,1-12H3;16-25H,1-15H3;13-24H,1-12H3;2*7-18H,19-21H2,1-6H3;1-12H,13-18H2;1H4.

What are the key properties of 2-[4-[4,6-bis[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[4,6-bis[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[4,6-bis[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;2-[4-[4,6-bis[4-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;methane;2,4,6-tris[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]pyrimidine;2,4,6-tris[5-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-3-pyridinyl]pyrimidine?

2-[4-[4,6-bis[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[4,6-bis[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[4,6-bis[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;2-[4-[4,6-bis[4-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;methane;2,4,6-tris[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]pyrimidine;2,4,6-tris[5-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-3-pyridinyl]pyrimidine has a molecular weight of 4057.13 g/mol, XLogP of 47.98, 39 rotatable bonds, 0 hydrogen bond donors, and 58 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[4-[4,6-bis[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[4,6-bis[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-[4-[4,6-bis[4-(5,5-dimethyl-4H-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-5,5-dimethyl-4H-1,3-oxazole;2-[4-[4,6-bis[4-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;methane;2,4,6-tris[5-(2,4,4,5,5-pentamethylimidazol-1-yl)-3-pyridinyl]pyrimidine;2,4,6-tris[5-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-3-pyridinyl]pyrimidine is sourced from PubChem (CID 158312841), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).